Pulse Biosciences, Inc. — Form D

Pulse Biosciences, Inc. of HAYWARD, CA, a company, filed a Form D exempt-offering notice with the SEC on 2021-07-09. The offering totals $50.0M, of which $50.0M was reported sold. Industry: Other Health Care.

Offering

• Filed: 2021-07-09
• Form: D
• Accession: 0001318083-21-000001
• Industry: Other Health Care
• Exemptions: 06b
• Total offering: $50.0M
• Amount sold: $50.0M
• Minimum investment: $50.0M
• Investors: 1
• Date of first sale: 2021-06-30
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-405734

Issuer

• Name: Pulse Biosciences, Inc.
• CIK: 0001625101
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2014
• Address: 3957 POINT EDEN WAY, HAYWARD, CA, 94545
• Phone: 510-906-4600

Officers, directors & promoters (25)

Other filings by this issuer (3)

More

• CIK 1625101 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search